Additional file 1: of Targeted gene panel for genetic testing of south Indian children with steroid resistant nephrotic syndrome

Table S1. Details of primers used for Sanger sequencing to validate the variants identified by next generation sequencing. Table S2. Detailed Clinical profile of the South Indian steroid resistant nephrotic syndrome cohort. Table S3. Ion PGM next-Generation Sequencing run summary. Table S4. Summary of per sample NGS data output and quality in Indian steroid resistant Nephrotic syndrome cohort. Table S5. Pathogenicity risk score of the Variant of unknown significance (VUS) (XLSX 25 kb)

补充表S1. 用于验证二代测序（next generation sequencing, NGS）所鉴定变异的桑格测序（Sanger sequencing）引物详情。
补充表S2. 印度南部类固醇抵抗性肾病综合征队列的详细临床特征。
补充表S3. Ion PGM 二代测序运行汇总。
补充表S4. 印度类固醇抵抗性肾病综合征队列中每样本二代测序数据产出与质量汇总。
补充表S5. 意义未明变异（Variant of unknown significance, VUS）的致病性风险评分（XLSX 25 kb）